343 related articles for article (PubMed ID: 29248558)
21. Gold nanoparticles generated and stabilized by water soluble curcumin-polymer conjugate: blood compatibility evaluation and targeted drug delivery onto cancer cells.
Manju S; Sreenivasan K
J Colloid Interface Sci; 2012 Feb; 368(1):144-51. PubMed ID: 22200330
[TBL] [Abstract][Full Text] [Related]
22. pH-responsive theranostic nanocomposites as synergistically enhancing positive and negative magnetic resonance imaging contrast agents.
Huang X; Yuan Y; Ruan W; Liu L; Liu M; Chen S; Zhou X
J Nanobiotechnology; 2018 Mar; 16(1):30. PubMed ID: 29587764
[TBL] [Abstract][Full Text] [Related]
23. HER2 Targeted Breast Cancer Therapy with Switchable "Off/On" Multifunctional "Smart" Magnetic Polymer Core-Shell Nanocomposites.
Vivek R; Thangam R; Kumar SR; Rejeeth C; Kumar GS; Sivasubramanian S; Vincent S; Gopi D; Kannan S
ACS Appl Mater Interfaces; 2016 Jan; 8(3):2262-79. PubMed ID: 26771508
[TBL] [Abstract][Full Text] [Related]
24. Tumor Penetrating Theranostic Nanoparticles for Enhancement of Targeted and Image-guided Drug Delivery into Peritoneal Tumors following Intraperitoneal Delivery.
Gao N; Bozeman EN; Qian W; Wang L; Chen H; Lipowska M; Staley CA; Wang YA; Mao H; Yang L
Theranostics; 2017; 7(6):1689-1704. PubMed ID: 28529645
[TBL] [Abstract][Full Text] [Related]
25. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors.
Jiang H; Geng D; Liu H; Li Z; Cao J
Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102
[TBL] [Abstract][Full Text] [Related]
26. Glucosamine-conjugated graphene quantum dots as versatile and pH-sensitive nanocarriers for enhanced delivery of curcumin targeting to breast cancer.
Ghanbari N; Salehi Z; Khodadadi AA; Shokrgozar MA; Saboury AA
Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111809. PubMed ID: 33579453
[TBL] [Abstract][Full Text] [Related]
27. pH- and thermo-sensitive MTX-loaded magnetic nanocomposites: synthesis, characterization, and in vitro studies on A549 lung cancer cell and MR imaging.
Farshbaf M; Salehi R; Annabi N; Khalilov R; Akbarzadeh A; Davaran S
Drug Dev Ind Pharm; 2018 Mar; 44(3):452-462. PubMed ID: 29098882
[TBL] [Abstract][Full Text] [Related]
28. Multifunctional MIL-Cur@FC as a theranostic agent for magnetic resonance imaging and targeting drug delivery:
Dehghani S; Hosseini M; Haghgoo S; Changizi V; Akbari Javar H; Khoobi M; Riahi Alam N
J Drug Target; 2020 Jul; 28(6):668-680. PubMed ID: 31886726
[TBL] [Abstract][Full Text] [Related]
29. Curcumin-entrapped MUC-1 aptamer targeted dendrimer-gold hybrid nanostructure as a theranostic system for colon adenocarcinoma.
Alibolandi M; Hoseini F; Mohammadi M; Ramezani P; Einafshar E; Taghdisi SM; Ramezani M; Abnous K
Int J Pharm; 2018 Oct; 549(1-2):67-75. PubMed ID: 30048777
[TBL] [Abstract][Full Text] [Related]
30. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy.
Lin M; Teng L; Wang Y; Zhang J; Sun X
Drug Deliv; 2016 May; 23(4):1420-5. PubMed ID: 26203688
[TBL] [Abstract][Full Text] [Related]
31. Theranostics Based on Iron Oxide and Gold Nanoparticles for Imaging- Guided Photothermal and Photodynamic Therapy of Cancer.
Rajkumar S; Prabaharan M
Curr Top Med Chem; 2017; 17(16):1858-1871. PubMed ID: 27875977
[TBL] [Abstract][Full Text] [Related]
32. Heparin-reduced graphene oxide nanocomposites for curcumin delivery: in vitro, in vivo and molecular dynamics simulation study.
Shi X; Wang Y; Sun H; Chen Y; Zhang X; Xu J; Zhai G
Biomater Sci; 2019 Feb; 7(3):1011-1027. PubMed ID: 30604794
[TBL] [Abstract][Full Text] [Related]
33. Formulation of curcumin delivery with functionalized single-walled carbon nanotubes: characteristics and anticancer effects in vitro.
Li H; Zhang N; Hao Y; Wang Y; Jia S; Zhang H; Zhang Y; Zhang Z
Drug Deliv; 2014 Aug; 21(5):379-87. PubMed ID: 24160816
[TBL] [Abstract][Full Text] [Related]
34. GSH-sensitive Pt(IV) prodrug-loaded phase-transitional nanoparticles with a hybrid lipid-polymer shell for precise theranostics against ovarian cancer.
Huang H; Dong Y; Zhang Y; Ru D; Wu Z; Zhang J; Shen M; Duan Y; Sun Y
Theranostics; 2019; 9(4):1047-1065. PubMed ID: 30867815
[No Abstract] [Full Text] [Related]
35. A novel theranostic system of AS1411 aptamer-functionalized albumin nanoparticles loaded on iron oxide and gold nanoparticles for doxorubicin delivery.
Baneshi M; Dadfarnia S; Shabani AMH; Sabbagh SK; Haghgoo S; Bardania H
Int J Pharm; 2019 Jun; 564():145-152. PubMed ID: 30978484
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of blood-brain barrier-stealth nanocomposites for in situ glioblastoma theranostics applications.
Su CH; Tsai CY; Tomanek B; Chen WY; Cheng FY
Nanoscale; 2016 Apr; 8(15):7866-70. PubMed ID: 27035391
[TBL] [Abstract][Full Text] [Related]
37. Metal nanoparticles: a theranostic nanotool against cancer.
Sharma H; Mishra PK; Talegaonkar S; Vaidya B
Drug Discov Today; 2015 Sep; 20(9):1143-51. PubMed ID: 26007605
[TBL] [Abstract][Full Text] [Related]
38. Iron oxide nanoparticle core-shell magnetic microspheres: Applications toward targeted drug delivery.
Ayyanaar S; Kesavan MP; Balachandran C; Rasala S; Rameshkumar P; Aoki S; Rajesh J; Webster TJ; Rajagopal G
Nanomedicine; 2020 Feb; 24():102134. PubMed ID: 31830615
[TBL] [Abstract][Full Text] [Related]
39. Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo.
Yan J; Wang Y; Zhang X; Liu S; Tian C; Wang H
Drug Deliv; 2016 Jun; 23(5):1757-62. PubMed ID: 26203689
[TBL] [Abstract][Full Text] [Related]
40. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment.
Cui T; Zhang S; Sun H
Oncol Rep; 2017 Feb; 37(2):1253-1260. PubMed ID: 28075466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
